Comprehensive genomic profiling of circulating cell-free DNA (cfDNA) distinguishes focal amplification (amp) from aneuploidy among MET amps in diverse advanced cancer types.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Tokyo Medical and Dental University, Guardant (United States), National Cancer Center Hospital East, Yonsei University, Yonsei University Health System, Yonsei Cancer Hospital, Soroka Medical Center, Clalit Health Services, National Cancer Center, Moores Cancer Center, Samsung Medical Center, Sungkyunkwan University, Prince of Wales Hospital
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2946966118
